Annual Operating Profit
-$55.73 M
-$4.75 M-9.31%
30 September 2023
Summary:
Anavex Life Sciences annual operaing income is currently -$55.73 million, with the most recent change of -$4.75 million (-9.31%) on 30 September 2023. During the last 3 years, it has fallen by -$13.78 million (-32.86%). AVXL annual operating profit is now -384251.72% below its all-time high of -$14.50 thousand, reached on 30 September 2004.AVXL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$14.73 M
-$2.68 M-22.26%
30 June 2024
Summary:
Anavex Life Sciences quarterly operating income is currently -$14.73 million, with the most recent change of -$2.68 million (-22.26%) on 30 June 2024. Over the past year, it has dropped by -$2.08 million (-16.42%). AVXL quarterly operating profit is now -359143.90% below its all-time high of -$4100.00, reached on 31 December 2004.AVXL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$50.72 M
-$1.20 M-2.42%
30 June 2024
Summary:
Anavex Life Sciences TTM operating income is currently -$50.72 million, with the most recent change of -$1.20 million (-2.42%) on 30 June 2024. Over the past year, it has increased by +$4.26 million (+7.75%). AVXL TTM operating profit is now -1236997.56% below its all-time high of -$4100.00, reached on 31 December 2004.AVXL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVXL Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -16.4% | +7.8% |
| 3 y3 years | -32.9% | -20.2% | -20.9% |
| 5 y5 years | -93.5% | -134.9% | -76.1% |
AVXL Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.9% | at low | -30.4% | +4.1% | -20.9% | +12.0% |
| 5 y | 5 years | -93.5% | at low | -134.9% | +4.1% | -76.9% | +12.0% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +4.1% | <-9999.0% | +12.0% |
Anavex Life Sciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$14.73 M(+22.3%) | -$50.72 M(+2.4%) |
| Mar 2024 | - | -$12.05 M(+6.7%) | -$49.52 M(-2.7%) |
| Dec 2023 | - | -$11.29 M(-10.7%) | -$50.92 M(-7.4%) |
| Sept 2023 | -$55.73 M(+9.3%) | -$12.65 M(-6.5%) | -$54.98 M(-4.6%) |
| June 2023 | - | -$13.53 M(+0.7%) | -$57.61 M(+1.9%) |
| Mar 2023 | - | -$13.44 M(-12.5%) | -$56.54 M(+3.5%) |
| Dec 2022 | - | -$15.36 M(+0.5%) | -$54.62 M(+7.1%) |
| Sept 2022 | -$50.99 M(+21.5%) | -$15.28 M(+22.7%) | -$50.99 M(+6.3%) |
| June 2022 | - | -$12.46 M(+8.2%) | -$47.95 M(+2.4%) |
| Mar 2022 | - | -$11.52 M(-1.7%) | -$46.85 M(+5.8%) |
| Dec 2021 | - | -$11.72 M(-4.3%) | -$44.28 M(+5.5%) |
| Sept 2021 | -$41.95 M(+35.6%) | -$12.25 M(+7.9%) | -$41.95 M(+12.8%) |
| June 2021 | - | -$11.36 M(+27.0%) | -$37.20 M(+9.6%) |
| Mar 2021 | - | -$8.94 M(-4.8%) | -$33.95 M(+3.8%) |
| Dec 2020 | - | -$9.40 M(+25.2%) | -$32.71 M(+5.7%) |
| Sept 2020 | -$30.94 M(+7.4%) | -$7.51 M(-7.4%) | -$30.94 M(+4.2%) |
| June 2020 | - | -$8.11 M(+5.3%) | -$29.70 M(+3.6%) |
| Mar 2020 | - | -$7.70 M(+0.9%) | -$28.67 M(-1.3%) |
| Dec 2019 | - | -$7.63 M(+21.6%) | -$29.03 M(+0.8%) |
| Sept 2019 | -$28.81 M(+50.2%) | -$6.27 M(-11.3%) | -$28.81 M(+1.6%) |
| June 2019 | - | -$7.07 M(-12.3%) | -$28.35 M(+9.8%) |
| Mar 2019 | - | -$8.07 M(+9.0%) | -$25.82 M(+14.8%) |
| Dec 2018 | - | -$7.40 M(+27.3%) | -$22.49 M(+17.2%) |
| Sept 2018 | -$19.18 M(+23.5%) | -$5.81 M(+28.0%) | -$19.18 M(+3.4%) |
| June 2018 | - | -$4.54 M(-4.0%) | -$18.55 M(+5.1%) |
| Mar 2018 | - | -$4.73 M(+15.7%) | -$17.64 M(+6.9%) |
| Dec 2017 | - | -$4.09 M(-21.0%) | -$16.50 M(+6.2%) |
| Sept 2017 | -$15.54 M(+0.6%) | -$5.18 M(+42.4%) | -$15.54 M(-8.1%) |
| June 2017 | - | -$3.64 M(+1.2%) | -$16.92 M(+9.0%) |
| Mar 2017 | - | -$3.59 M(+14.6%) | -$15.53 M(+10.2%) |
| Dec 2016 | - | -$3.13 M(-52.2%) | -$14.09 M(-5.3%) |
| Sept 2016 | -$15.45 M(+117.3%) | -$6.56 M(+191.9%) | -$14.88 M(+21.1%) |
| June 2016 | - | -$2.25 M(+4.3%) | -$12.29 M(+6.3%) |
| Mar 2016 | - | -$2.15 M(-45.1%) | -$11.56 M(+12.6%) |
| Dec 2015 | - | -$3.92 M(-1.1%) | -$10.26 M(+44.3%) |
| Sept 2015 | -$7.11 M(+139.4%) | -$3.97 M(+162.2%) | -$7.11 M(+88.0%) |
| June 2015 | - | -$1.51 M(+76.3%) | -$3.78 M(+15.7%) |
| Mar 2015 | - | -$858.30 K(+11.4%) | -$3.27 M(-4.7%) |
| Dec 2014 | - | -$770.70 K(+20.5%) | -$3.43 M(+15.5%) |
| Sept 2014 | -$2.97 M | -$639.40 K(-36.0%) | -$2.97 M(-21.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$998.80 K(-2.2%) | -$3.80 M(+29.8%) |
| Mar 2014 | - | -$1.02 M(+229.8%) | -$2.93 M(+44.0%) |
| Dec 2013 | - | -$309.60 K(-78.9%) | -$2.03 M(-5.0%) |
| Sept 2013 | -$2.14 M(-50.5%) | -$1.47 M(+1065.4%) | -$2.14 M(+63.1%) |
| June 2013 | - | -$126.00 K(-0.9%) | -$1.31 M(-30.3%) |
| Mar 2013 | - | -$127.10 K(-69.4%) | -$1.88 M(-26.2%) |
| Dec 2012 | - | -$415.40 K(-35.2%) | -$2.55 M(-41.0%) |
| Sept 2012 | -$4.32 M(-30.1%) | -$641.40 K(-7.9%) | -$4.32 M(-11.9%) |
| June 2012 | - | -$696.30 K(-12.4%) | -$4.90 M(-16.1%) |
| Mar 2012 | - | -$794.70 K(-63.7%) | -$5.84 M(-16.5%) |
| Dec 2011 | - | -$2.19 M(+78.6%) | -$6.99 M(+13.3%) |
| Sept 2011 | -$6.17 M(+9.3%) | -$1.22 M(-25.1%) | -$6.17 M(-10.7%) |
| June 2011 | - | -$1.63 M(-16.0%) | -$6.91 M(+5.0%) |
| Mar 2011 | - | -$1.95 M(+42.3%) | -$6.58 M(+7.0%) |
| Dec 2010 | - | -$1.37 M(-30.4%) | -$6.15 M(+8.6%) |
| Sept 2010 | -$5.65 M(+19.3%) | -$1.96 M(+50.7%) | -$5.66 M(+3.0%) |
| June 2010 | - | -$1.30 M(-14.1%) | -$5.50 M(+0.8%) |
| Mar 2010 | - | -$1.52 M(+72.4%) | -$5.46 M(+15.9%) |
| Dec 2009 | - | -$880.00 K(-51.1%) | -$4.71 M(-0.5%) |
| Sept 2009 | -$4.73 M(-10.2%) | -$1.80 M(+43.3%) | -$4.73 M(-15.7%) |
| June 2009 | - | -$1.26 M(+63.2%) | -$5.62 M(+4.9%) |
| Mar 2009 | - | -$770.00 K(-15.0%) | -$5.36 M(+1.9%) |
| Dec 2008 | - | -$905.80 K(-66.3%) | -$5.26 M(-1.5%) |
| Sept 2008 | -$5.27 M(+234.0%) | -$2.69 M(+169.9%) | -$5.34 M(+40.7%) |
| June 2008 | - | -$995.00 K(+48.1%) | -$3.79 M(+24.2%) |
| Mar 2008 | - | -$671.70 K(-32.0%) | -$3.06 M(+19.7%) |
| Dec 2007 | - | -$987.50 K(-13.4%) | -$2.55 M(+61.8%) |
| Sept 2007 | -$1.58 M(+6063.7%) | -$1.14 M(+346.3%) | -$1.58 M(+256.5%) |
| June 2007 | - | -$255.60 K(+51.4%) | -$442.50 K(+129.8%) |
| Mar 2007 | - | -$168.80 K(+1272.4%) | -$192.60 K(+575.8%) |
| Dec 2006 | - | -$12.30 K(+112.1%) | -$28.50 K(+11.3%) |
| Sept 2006 | -$25.60 K(-72.1%) | -$5800.00(+1.8%) | -$25.60 K(-58.6%) |
| June 2006 | - | -$5700.00(+21.3%) | -$61.80 K(-39.3%) |
| Mar 2006 | - | -$4700.00(-50.0%) | -$101.80 K(-28.7%) |
| Dec 2005 | - | -$9400.00(-77.6%) | -$142.80 K(+3.9%) |
| Sept 2005 | -$91.70 K(+532.4%) | -$42.00 K(-8.1%) | -$137.50 K(+44.0%) |
| June 2005 | - | -$45.70 K(0.0%) | -$95.50 K(+91.8%) |
| Mar 2005 | - | -$45.70 K(+1014.6%) | -$49.80 K(+1114.6%) |
| Dec 2004 | - | -$4100.00 | -$4100.00 |
| Sept 2004 | -$14.50 K | - | - |
FAQ
- What is Anavex Life Sciences annual operaing income?
- What is the all time high annual operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly operating income?
- What is the all time high quarterly operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly operating profit year-on-year change?
- What is Anavex Life Sciences TTM operating income?
- What is the all time high TTM operating profit for Anavex Life Sciences?
- What is Anavex Life Sciences TTM operating profit year-on-year change?
What is Anavex Life Sciences annual operaing income?
The current annual operating profit of AVXL is -$55.73 M
What is the all time high annual operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high annual operaing income is -$14.50 K
What is Anavex Life Sciences quarterly operating income?
The current quarterly operating profit of AVXL is -$14.73 M
What is the all time high quarterly operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly operating income is -$4100.00
What is Anavex Life Sciences quarterly operating profit year-on-year change?
Over the past year, AVXL quarterly operating income has changed by -$2.08 M (-16.42%)
What is Anavex Life Sciences TTM operating income?
The current TTM operating profit of AVXL is -$50.72 M
What is the all time high TTM operating profit for Anavex Life Sciences?
Anavex Life Sciences all-time high TTM operating income is -$4100.00
What is Anavex Life Sciences TTM operating profit year-on-year change?
Over the past year, AVXL TTM operating income has changed by +$4.26 M (+7.75%)